Bosch, M. J., R. L. Earl, K. Fargnoli, S. Pacciafuoco, and F. Giombini. 1989. Identification of the fusion peptide of primate immunodeficiency viruses. Science 244:694-697.
Bruck, C., S. Mathot, D. Portetelle, C. Berte, J. D. Fransen, P. Henrion, and A. Burny. 1982. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 122:342-352.
Bruck, C., D. Portetelle, A. Burny, and J. Zavada. 1982. Topographical anligenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 122:353-362.
Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. van den Broeke, L. Willems, and R. Thomas. 1990. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer, p. 9-25. In R. Gallo and F. Wong Staal (ed.), Retrovirus biology and human disease. Marcel Dekker, New York.
Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. van den Broeke, L. Willems, and R. Thomas. 1988. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer. Vet. Microbiol. 17:197-218.
Busetta, B. 1989. The use of folding patterns in multisolution approach of the all-β protein three dimensional structure. A β-roll structure is predicted in the retroviral glycoproteins. Biochim. Biophys. Acta 998:301-309.
Callebaut, I., D. Portetelle, A. Burny, and J. P. Mornon. 1994. Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data. Eur. J. Biochem. 222:405-414.
Dales, S., and R. Kajioka. 1964. The cycle of multiplication of vaccinia virus in Earle's strain L cells. Virology 24:278-294.
Doms, R. W., R. Blumenthal, and B. Moss. 1990. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64:4884-4892.
Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of human immunodeficiency virus type I envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654.
Ho, D. D., J. C. Kaplan, I. E. Rackauskas, and M. E. Gurney. 1988. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239:1021-1023.
Hoekstra, D., T. DeBoer, K. Klappe, and J. Wilschut. 1984. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675-5681.
Keller, P. M., S. Person, and W. Snipes. 1977. A fluorescence enhancement assay of the cell fusion. J. Cell. Sci. 28:167-177.
Kettmann, R., A. Burny, I. Callebaut, L. Droogmans, M. Mammerickx, L. Willems, and D. Portetelle. 1994. Bovine leukemia virus, p. 39-81. In J. A. Levy (ed.), The Retroviridea, vol. 3. Plenum Press, New York.
Konopka, K., E. Pretzer, and N. Düzgünes. 1995. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity. Biochem. Biophys. Res. Comm. 208:75-81.
Kowalski, M., J. Potz, L. Basiripour, T. Doftman, W. Chun Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the human immunodeficiency virus envelope glycoprotein. Science 237:1351-1355.
Larsen, C. E., D. R. Alford, L. J. T. Young, T. P. McGraw, and N. Düzgünes. 1990. Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membrane: effects of lipid composition, pH and calcium. J. Gen. Virol. 71:1947-1955.
Pantaleo, G., G. Poli, L. Boutini, C. Fox, A. I. Dayton, and A. S. Fauci. 1991. Dissociation between syncytia formation and HIV spreading. Suppression of syncytia does not necessarily reflect inhibition of HIV infection. Eur. J. Immunol. 21:1771-1774.
Rice, N. R., R. M. Stephens, and R. V. Gilden. 1987. Sequence analysis of bovine leukemia virus genome, p. 115-144. In A. Burny and M. Mammerickx (ed.), Enzootic bovine leukosis and bovine leukemia virus. Martinus Nijhoff, Boston.
Sinangil, F., A. Loyter, and D. J. Volsky. 1988. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett. 239:88-92.
Skinner, M. A., A. J. Langlois, C. B. McDanal, J. S. McDougal, D. P. Bolognesi, and T. J. Matthews. 1988. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J. Virol. 62:4195-4200.
Vonèche, V., D. Portetelle, R. Kettmann, L. Willems, K. Limbach, E. Paoletti, J. M. Ruysschaert, A. Burny, and R. Brasseur. 1992. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion via oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. USA 89:3810-3814.
White, J. 1990. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:675-697.
White, J., M. Kielian, and A. Q. Helenius. 1983. Membrane fusion proteins of enveloped animal viruses. Quart. Rev. Biophys. 16:151-195.
Willems, L., E. Thienpont, P. Kerkhofs, A. Burny, M. Mammerickx, and R. Kettmann. 1993. Bovine leukemia virus, an animal model for the study of intrastain variability. J. Virol. 67:1086-1089.
Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
Wilson, C. A., J. W. Marsh, and M. V. Eiden. 1992. The requirements of viral entry differ from those for virally induced syncytia formation in NIH3T3/DTras cell exposed to Moloney murine leukemia virus. J. Virol. 66:7262-7269.
Wunderlli-Allenspach, H., M. Günthert, and S. Ott. 1993. Inactivation of PR8 influenza virus through the octadecylrhodamine B chloride membrane marker. Biochemistry 32:900-907.
